Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 191,000 KRW
Change Today -2,000.00 / -1.04%
Volume 43.2K
006280 On Other Exchanges
Korea SE
As of 12:19 AM 04/22/15 All times are local (Market data is delayed by at least 15 minutes).

green cross corp (006280) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/20/15 - 202,000
52 Week Low
08/21/14 - 116,500
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GREEN CROSS CORP (006280)

Related News

No related news articles were found.

green cross corp (006280) Related Businessweek News

No Related Businessweek News Found

green cross corp (006280) Details

Green Cross Corp. manufactures and sells medicine and medical supplies primarily in South Korea. The company produces blood derivatives, including immunoglobulin, hemophilia drug, antithrombin, and tetanus immunoglobulin; vaccines for diseases, such as hepatitis B, prophylaxis of varicella, Japanese encephalitis, and influenza; prescription drugs for hunter syndrome, cerebral diseases, and chronic diseases comprising high blood pressure, hyperlipidemia, and diabetes. It also produces over the counter drugs, such as anti-inflammatory analgesic drugs, allergic skin disease creams, patch products, nutritional supplement products, painkiller products, and respiratory organ drug products, as well as bruises, muscle aches, and joint pain drugs. Green Cross Corp. exports its products to approximately 30 countries. The company was formerly known as Sudo Microorganism Medical Supplies Co. changed its name to Green Cross Corp. in 1971. Green Cross Corp. was founded in 1967 and is headquartered in Yongin, South Korea.

Founded in 1967

green cross corp (006280) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

green cross corp (006280) Key Developments

GC Corp. Proposes Changes to Articles of Incorporation

GC Corp. announced at the AGM to be held on March 20, 2015, it will propose some changes to articles of incorporation.

Green Cross Corp., Annual General Meeting, Mar 20, 2015

Green Cross Corp., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Agenda: To consider consolidated financial statements for the period ended December 31, 2014; to approve some changes to articles of incorporation; to appoint senior director; and to approve director remuneration.

Green Cross Corp. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM

Green Cross Corp. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Byung-Geon Rhee, Chief Executive Officer and President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
006280:KS 191,000.00 KRW -2,000.00

006280 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bavarian Nordic A/S kr336.50 DKK -2.00
CSL Ltd A$92.52 AUD -0.295
Emergent Biosolutions Inc $29.97 USD +0.14
GeoVax Labs Inc $0.17 USD 0.00
Valneva SE €4.09 EUR +0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation 006280 Industry Range
Price/Earnings 26.8x
Price/Sales 2.3x
Price/Book 2.5x
Price/Cash Flow 26.0x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GREEN CROSS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at